Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients Journal Article


Authors: Earle, C. C.; Schrag, D.; Neville, B. A.; Yabroff, K. R.; Topor, M.; Fahey, A.; Trimble, E. L.; Bodurka, D. C.; Bristow, R. E.; Carney, M.; Warren, J. L.
Article Title: Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients
Abstract: Background: For many diseases, specialized care (i.e., care rendered by a specialist) has been associated with superior-quality care (i.e., better outcomes). We examined associations between physician specialty and outcomes in a population-based cohort of elderly ovarian cancer surgery patients. Methods: We analyzed the Medicare claims, by physician specialty, of all women aged 65 years or older who underwent surgery for pathologically confirmed invasive epithelial ovarian cancer between January 1, 1992, and December 31, 1999, while living in an area monitored by the Surveillance, Epidemiology, and End Results (SEER) program to assess important care processes (i.e., the appropriate extent of surgery and use of adjuvant chemotherapy) and outcomes (i.e., surgical complications, ostomy rates, and survival). All statistical tests were two-sided. Results: Among 3067 ovarian cancer patients who underwent surgery, 1017 patients (33%) were treated by a gynecologic oncologist, 1377 patients (45%) by a general gynecologist, and 673 patients (22%) by a general surgeon. Among patients with stage I or II disease, those treated by a gynecologic oncologist (60%) were more likely to undergo lymph node dissection than those treated by a general gynecologist (36%) or a general surgeon (16%). Patients with stage III or IV disease were more likely to undergo a debulking procedure if the initial surgery was performed by a gynecologic oncologist (58%) than by a general gynecologist (51%) or a general surgeon (40%; P<.001) and were more likely to receive postoperative chemotherapy when operated on by a gynecologic oncologist (79%) or a general gynecologist (76%) than by a general surgeon (62%, P<.001). Survival among patients operated on by gynecologic oncologists (hazard ratio [HR] of death from any cause = 0.85, 95% confidence interval [CI] = 0.76 to 0.95) or general gynecologists (HR = 0.86, 95% CI = 0.78 to 0.96) was better than that among patients operated on by general surgeons. Conclusions: Ovarian cancer patients treated by gynecologic oncologists had marginally better outcomes than those treated by general gynecologists and clearly superior outcomes compared with patients treated by general surgeons. © The Author 2006. Published by Oxford University Press. All rights reserved.
Keywords: cancer survival; controlled study; treatment outcome; aged; aged, 80 and over; survival analysis; cancer surgery; survival rate; major clinical study; united states; cancer adjuvant therapy; cancer patient; postoperative care; cancer staging; outcome assessment; neoplasm staging; lymph node excision; cytoreductive surgery; ovarian neoplasms; ovary cancer; proportional hazards models; ovariectomy; cohort analysis; odds ratio; oncology; risk assessment; postoperative complication; confidence interval; confidence intervals; medicare; patient care; statistical analysis; surgeon; stoma; outcome and process assessment (health care); surgery; cancer registry; seer program; platinum complex; analysis of variance; gynecology; general surgery
Journal Title: JNCI: Journal of the National Cancer Institute
Volume: 98
Issue: 3
ISSN: 0027-8874
Publisher: Oxford University Press  
Date Published: 2006-02-01
Start Page: 172
End Page: 180
Language: English
DOI: 10.1093/jnci/djj019
PUBMED: 16449677
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 139" - "Export Date: 4 June 2012" - "CODEN: JNCIA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Deborah Schrag
    235 Schrag